Nadin Silvina B, Cuello-Carrión F Darío, Cayado-Gutiérrez Niubys, Fanelli Mariel A
Laboratorio de Biología Tumoral, Instituto de Medicina y Biología Experimental de Cuyo (IMBECU), Universidad Nacional de Cuyo, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Centro Científico Tecnológico (CCT), Mendoza 5500, Argentina.
Laboratorio de Oncología, IMBECU, CONICET, CCT, Mendoza 5500, Argentina.
Biology (Basel). 2025 Feb 11;14(2):185. doi: 10.3390/biology14020185.
The Wnt/β-catenin pathway takes part in important cellular processes in tumor cells, such as gene expression, adhesion, and survival. The canonical pathway is activated in several tumors, and β-catenin is its major effector. The union of Wnt to the co-receptor complex causes the inhibition of GSK3β activity, thus preventing the phosphorylation and degradation of β-catenin, which accumulates in the cytoplasm, to subsequently be transported to the nucleus to associate with transcription factors. The relationship between Wnt/β-catenin and DNA damage/repair mechanisms has been a focus for the last few years. Studying the Wnt/β-catenin network interactions with DNA damage/repair proteins has become a successful research field. This review provides an overview of the participation of Wnt/β-catenin in DNA damage/repair mechanisms and their future implications as targets for cancer therapy.
Biology (Basel). 2025-2-11
Front Oncol. 2022-3-14
Biochem Biophys Res Commun. 2010-1-20
Genes (Basel). 2024-12-13
Biochem Pharmacol. 2024-12
Biochim Biophys Acta Rev Cancer. 2024-11
DNA Repair (Amst). 2024-7
Front Oncol. 2024-4-25